# Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

> **NCT00268554** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Hyperemia
- Hypoxia

## Interventions

- **DRUG:** dipyridamole
- **DRUG:** caffeine

## Key facts

- **NCT ID:** NCT00268554
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2008-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268554, "Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00268554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*